Berry, Jamie
Jacomb, Isabella
Lunn, Jo
Sedwell, Antoinette
Shakeshaft, Anthony
Kelly, Peter J
Sarrami, Pooria
James, Megan
Russell, Skye
Nardo, Talia https://orcid.org/0000-0001-7881-2568
Barker, Daniel
Holmes, Jennifer
Funding for this research was provided by:
Drug and Alcohol Network:Agency for Clinical Innovation (nil)
Article History
Received: 7 August 2018
Accepted: 30 January 2019
First Online: 13 February 2019
Ethics approval and consent to participate
: Participants will give informed consent before participating in the above research. The Macquarie University Human Research Ethics Committee (HREC (Medical Science)) approved the research to trial (Reference Number 5201800077), which is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12618001190291). All participants will provide written informed consent to a research officer prior to participating in the trial. Consent will be provided separately for access to linked healthcare data through the Centre for Health Record Linkage. Participants will also able to request to withdraw from the study at any point during their participation (data collection, intervention or both). Any adverse events will be reported to the primary investigator and managed on a case by case basis, with participant wellbeing a priority. Digital copies of personal information such as contact details will be kept separately to study data only on a secure server, for the minimum duration necessary to allow for linking of baseline and follow-up data. Trial results will be communicated to site leads at the residential AOD services that participated in the study. Participants will be provided with the contact details of the researchers in order to request trial results following completion of the study. No individual level feedback will be provided.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.